When ReproTech staff member Jamie was diagnosed with PCOS after several years of trying to conceive, she faced setback after setback—until a new path through IVF gave her and her spouse hope again. This honest and heartfelt story traces the emotional highs and lows of fertility treatment, the strength she discovered in herself, and the arrival of her daughter, Melanie. A moving reminder that even the hardest journeys can lead to something beautiful.
We’re excited to welcome Cristian Milevski as ReproTech’s new Biorepository Manager! With extensive experience as an Andrologist and Embryologist, Cristian brings valuable insight and leadership to our cryostorage operations. His expertise will enhance our services, ensuring the highest level of security and reliability for our clinic partners and their patients.
We asked Cristian a few key questions about his role and how his experience will benefit clinics like yours—read the Q&A below!
In recognition of Breast Cancer Awareness Month, we’re honored to share Megan’s fertility preservation journey and her decision to trust ReproTech as the long-term cryostorage partner for her precious eggs. Here’s her story:
ReproTech, the industry leader in human reproductive tissue cryogenic storage, has appointed Brad Senstra as Chief Executive Officer. Mr. Senstra brings to ReproTech more than 16 years of experience in fertility and reproductive medicine. Before accepting this position, he served as Executive Director of Seattle Reproductive Medicine (“SRM”). Mr. Senstra is a noted thought leader in reproductive medicine and has presented at numerous American Society for Reproductive Medicine meetings and events over the past 16 years. He also served on the Association of Reproductive Managers Board from 2014-2017. Mr. Senstra earned his Master's of Health Administration from the University of [Read More...]
We at ReproTech are aware of the need for improved access to preserving fertility before cancer treatment and have long partnered with oncologists nationwide to provide an avenue of affordable and safe cryostorage for their patients’ reproductive specimens. Research shows that patients facing fertility-threatening treatments and thus at risk for infertility must be educated about the chances early in treatment planning. UPMC-Magee’s study, published in March 2023, is one of many studies showing a critical need for improved access to fertility preservation for all who want to have a future family following disease recovery.
For active-duty military personnel preparing for deployment, storing frozen eggs or
sperm can be a valuable way to protect future family-building options. Deployment,
especially in combat zones, may carry an increased risk of infertility, and cryostoring
eggs or sperm before deployment offers a proactive approach to safeguarding fertility.
ReproTech specializes in long-term cryostorage of human reproductive tissues (embryos, oocytes, semen, testicular/ovarian tissues). Here we answer commonly asked questions about shipping and storing these tissues with ReproTech.
We specialize in the cryostorage of human reproductive tissues. You may wonder how long an embryo can be frozen and remain viable after so many years. How are embryos frozen, and do they result in a pregnancy as often as a fresh embryo? And last, how does ReproTech fit into the family-building journey? We’re here to give you a quick overview!